Hra Psychological Services Pc | |
2851 Charlevoix Dr Se Ste 323 Grand Rapids MI 49546-7092 | |
(616) 458-0692 | |
(616) 458-8129 |
Full Name | Hra Psychological Services Pc |
---|---|
Speciality | Psychologist |
Location | 2851 Charlevoix Dr Se Ste 323, Grand Rapids, Michigan |
Authorized Official Name and Position | Tracy Heckman (PRACTICE MANAGER) |
Authorized Official Contact | 6164580692 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Hra Psychological Services Pc 2851 Charlevoix Dr Se Ste 323 Grand Rapids MI 49546-7092 Ph: (616) 458-0692 | Hra Psychological Services Pc 2851 Charlevoix Dr Se Ste 323 Grand Rapids MI 49546-7092 Ph: (616) 458-0692 |
NPI Number | 1003859984 |
---|---|
Provider Enumeration Date | 06/14/2006 |
Last Update Date | 11/16/2023 |
Certification Date | 11/16/2023 |
Medicare PECOS PAC ID | 8820994031 |
---|---|
Medicare Enrollment ID | O20031209000700 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1003859984 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
Provider Name | Matthew M Ready |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1528256286 PECOS PAC ID: 0840387536 Enrollment ID: I20071026000668 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Provider Name | Amy L Jarchow |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1952480915 PECOS PAC ID: 6002914769 Enrollment ID: I20080430000813 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Provider Name | Robert J Baird |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1932136165 PECOS PAC ID: 9638172364 Enrollment ID: I20080717000192 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Provider Name | Robert J Shaffer |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1720016959 PECOS PAC ID: 8820283906 Enrollment ID: I20101115000946 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Provider Name | Thomas C Fuller |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1598705675 PECOS PAC ID: 3870788961 Enrollment ID: I20101115001023 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Provider Name | Omar L Mangrum |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1457389157 PECOS PAC ID: 8820277130 Enrollment ID: I20110119000318 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Provider Name | Thomas M Spahn |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1467489914 PECOS PAC ID: 7618873829 Enrollment ID: I20110302000904 |
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
News Archive
In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.
In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will report findings suggesting an increased risk of early (less than 35 weeks) preterm birth when intra-amniotic debris is present in nulliparous women with a short cervix.
At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research.
Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.
› Verified 7 days ago
Reclaim Life Therapy Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 800 Monroe Ave Nw, Ste 300, Grand Rapids, MI 49503 Phone: 616-309-0107 Fax: 616-825-6185 | |
Bridges Counseling Services Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3280 E Beltline Ct Ne, Grand Rapids, MI 49525 Phone: 616-447-3404 | |
Tru Behavior Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 941 Joslin St Se, Grand Rapids, MI 49507 Phone: 616-287-0740 | |
Perennial Health Services Plc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 233 E Fulton St, Suite 114, Grand Rapids, MI 49503 Phone: 616-633-7203 Fax: 616-427-3023 | |
Heart Of The City Health Center West Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 Sheldon Blvd Se, Grand Rapids, MI 49503 Phone: 616-965-8282 Fax: 616-940-5366 | |
Thriveworks Counseling Grand Rapids Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4079 Park East Ct Se, Suite C, Grand Rapids, MI 49546 Phone: 269-823-4873 |